Dr Richard Lefroy Bailey, MD | |
3750 Hwy 95, Suite 101, Bullhead City, AZ 86442-6050 | |
(928) 763-1020 | |
(928) 763-2076 |
Full Name | Dr Richard Lefroy Bailey |
---|---|
Gender | Male |
Speciality | Otolaryngology |
Experience | 35 Years |
Location | 3750 Hwy 95, Bullhead City, Arizona |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1477553543 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207YX0905X | Otolaryngology - Otolaryngology/facial Plastic Surgery | 25327 (Arizona) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Kingman Regional Medical Center | Kingman, AZ | Hospital |
Western Arizona Regional Medical Center | Bullhead city, AZ | Hospital |
Valley View Medical Center | Fort mohave, AZ | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Bullhead City Clinic Corp | 1052317575 | 25 |
News Archive
Scientists have discovered that in rheumatoid arthritis patients, lower levels of vitamin D are associated with increased disease severity.
INTEGRA has expanded its popular reagent reservoir product family to include polypropylene reservoirs with enhanced chemical compatibility that perfectly complements the existing polystyrene reservoirs.
Nightingale Informatix Corporation, an application service provider (ASP) of electronic medical record (EMR) software and related services, announces its financial results for the quarter and year ended March 31, 2011. All results are reported in Canadian dollars unless otherwise stated.
Angiotech Pharmaceuticals, Inc. today announced that its corporate partner, Boston Scientific Corporation, announced 12-month results from its PERSEUS clinical program that demonstrated positive safety and efficacy outcomes in workhorse lesions for the platinum chromium TAXUS(R) Element(TM) Paclitaxel-Eluting Stent System compared to the TAXUS(R) Express(TM) Paclitaxel-Eluting Stent System.
› Verified 9 days ago
Entity Name | Bullhead City Clinic Corp |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1962429878 PECOS PAC ID: 1052317575 Enrollment ID: O20061005000614 |
News Archive
Scientists have discovered that in rheumatoid arthritis patients, lower levels of vitamin D are associated with increased disease severity.
INTEGRA has expanded its popular reagent reservoir product family to include polypropylene reservoirs with enhanced chemical compatibility that perfectly complements the existing polystyrene reservoirs.
Nightingale Informatix Corporation, an application service provider (ASP) of electronic medical record (EMR) software and related services, announces its financial results for the quarter and year ended March 31, 2011. All results are reported in Canadian dollars unless otherwise stated.
Angiotech Pharmaceuticals, Inc. today announced that its corporate partner, Boston Scientific Corporation, announced 12-month results from its PERSEUS clinical program that demonstrated positive safety and efficacy outcomes in workhorse lesions for the platinum chromium TAXUS(R) Element(TM) Paclitaxel-Eluting Stent System compared to the TAXUS(R) Express(TM) Paclitaxel-Eluting Stent System.
› Verified 9 days ago
Mailing Address | Practice Location Address |
---|---|
Dr Richard Lefroy Bailey, MD Po Box 21944, Bullhead City, AZ 86439-1944 Ph: (928) 763-1020 | Dr Richard Lefroy Bailey, MD 3750 Hwy 95, Suite 101, Bullhead City, AZ 86442-6050 Ph: (928) 763-1020 |
News Archive
Scientists have discovered that in rheumatoid arthritis patients, lower levels of vitamin D are associated with increased disease severity.
INTEGRA has expanded its popular reagent reservoir product family to include polypropylene reservoirs with enhanced chemical compatibility that perfectly complements the existing polystyrene reservoirs.
Nightingale Informatix Corporation, an application service provider (ASP) of electronic medical record (EMR) software and related services, announces its financial results for the quarter and year ended March 31, 2011. All results are reported in Canadian dollars unless otherwise stated.
Angiotech Pharmaceuticals, Inc. today announced that its corporate partner, Boston Scientific Corporation, announced 12-month results from its PERSEUS clinical program that demonstrated positive safety and efficacy outcomes in workhorse lesions for the platinum chromium TAXUS(R) Element(TM) Paclitaxel-Eluting Stent System compared to the TAXUS(R) Express(TM) Paclitaxel-Eluting Stent System.
› Verified 9 days ago